CD34 and neoplasm: On the other hand, CD34 is often used to assess the microvessel density (MVD) of tumour tissues, including NSCLC, and is closely related to tumour angiogenesis, invasiveness, and microenvironmental constitutive cellular activity (Tanaka et al. 2001, 2003; Schulze et al. 2020).